These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 18216394
1. Development of binding assays for the SH2 domain of Grb7 and Grb2 using fluorescence polarization. Luzy JP, Chen H, Gril B, Liu WQ, Vidal M, Perdereau D, Burnol AF, Garbay C. J Biomol Screen; 2008 Feb; 13(2):112-9. PubMed ID: 18216394 [Abstract] [Full Text] [Related]
2. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor. Nioche P, Liu WQ, Broutin I, Charbonnier F, Latreille MT, Vidal M, Roques B, Garbay C, Ducruix A. J Mol Biol; 2002 Feb 01; 315(5):1167-77. PubMed ID: 11827484 [Abstract] [Full Text] [Related]
8. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives. Song YL, Peach ML, Roller PP, Qiu S, Wang S, Long YQ. J Med Chem; 2006 Mar 09; 49(5):1585-96. PubMed ID: 16509576 [Abstract] [Full Text] [Related]
9. Identification of novel non-phosphorylated ligands, which bind selectively to the SH2 domain of Grb7. Pero SC, Oligino L, Daly RJ, Soden AL, Liu C, Roller PP, Li P, Krag DN. J Biol Chem; 2002 Apr 05; 277(14):11918-26. PubMed ID: 11809769 [Abstract] [Full Text] [Related]
11. Identification of Tyr-703 and Tyr-936 as the primary association sites for Grb2 and Grb7 in the c-Kit/stem cell factor receptor. Thömmes K, Lennartsson J, Carlberg M, Rönnstrand L. Biochem J; 1999 Jul 01; 341 ( Pt 1)(Pt 1):211-6. PubMed ID: 10377264 [Abstract] [Full Text] [Related]
12. Structure-based design and synthesis of high affinity tripeptide ligands of the Grb2-SH2 domain. Furet P, Gay B, Caravatti G, García-Echeverría C, Rahuel J, Schoepfer J, Fretz H. J Med Chem; 1998 Aug 27; 41(18):3442-9. PubMed ID: 9719597 [Abstract] [Full Text] [Related]
13. Structural determinants of the interaction between the erbB2 receptor and the Src homology 2 domain of Grb7. Janes PW, Lackmann M, Church WB, Sanderson GM, Sutherland RL, Daly RJ. J Biol Chem; 1997 Mar 28; 272(13):8490-7. PubMed ID: 9079677 [Abstract] [Full Text] [Related]
14. Progress towards the development of SH2 domain inhibitors. Kraskouskaya D, Duodu E, Arpin CC, Gunning PT. Chem Soc Rev; 2013 Apr 21; 42(8):3337-70. PubMed ID: 23396540 [Abstract] [Full Text] [Related]
18. Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain. Song YL, Tan J, Luo XM, Long YQ. Org Biomol Chem; 2006 Feb 21; 4(4):659-66. PubMed ID: 16467940 [Abstract] [Full Text] [Related]
19. Solution structure of the human Grb14-SH2 domain and comparison with the structures of the human Grb7-SH2/erbB2 peptide complex and human Grb10-SH2 domain. Scharf PJ, Witney J, Daly R, Lyons BA. Protein Sci; 2004 Sep 21; 13(9):2541-6. PubMed ID: 15322292 [Abstract] [Full Text] [Related]